The FDA Approved a New Flu Treatment, Just In Time for Flu Season

The Food and Drug Administration (FDA) has approved a new antiviral influenza treatment.

The agency on Wednesday approved Genentech's drug Xofluza, which can be taken via a single oral dose to help patients recover more quickly from the flu. It's the "first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years," FDA Commissioner Dr. Scott Gottlieb said in a statement.